Titelia

Holdings of Exome Asset Management LLC

40 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 49.7 % of the equity sleeve

Sector breakdown

  • Health care 20.4 %
  • Industrials 5.2 %
  • Unattributed 74.4 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 97.3 %
  • KY 2.7 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US38154.8M $97.29 %
2KY24.3M $2.71 %

Positions

RankCompanySharesValueWeight
1Praxis Precision Medicines Inc 45,46914.6M $
2Cogent Biosciences Inc 278,53310.7M $
3Enliven Therapeutics Inc 220,0918.6M $
4Ionis Pharmaceuticals Inc 110,0648.3M $
5Guardant Health Inc 82,7367.6M $
6Cytokinetics Inc 103,7186.8M $
7Eli Lilly & Co 7,0126.4M $
8Alumis Inc 279,1766.2M $
9Bridgebio Pharma Inc 67,4925M $
10Vera Therapeutics Inc 114,9914.6M $
11Insmed Inc 26,6514.4M $
12Elevance Health Inc 14,6774.3M $
13Agios Pharmaceuticals Inc 125,0604.2M $
14United Therapeutics Corp 7,0534.2M $
15Natera Inc 18,6503.7M $
16Rhythm Pharmaceuticals Inc 40,5813.5M $
17UnitedHealth Group Inc 12,8623.5M $
18Apellis Pharmaceuticals Inc 85,5173.4M $
19Verastem Inc 636,7003.4M $
2010X Genomics Inc 154,1943.3M $
21Boston Scientific Corp 48,3473M $
22Monte Rosa Therapeutics Inc 179,4843M $
23Intuitive Surgical Inc 6,3582.9M $
24ADAGENE INC 736,8452.9M $
25Arrowhead Pharmaceuticals Inc 45,7212.9M $
26Relay Therapeutics Inc 278,3022.8M $
27Maze Therapeutics Inc 88,5102.6M $
28CytomX Therapeutics Inc 521,4682.5M $
29AVALO THERAPEUTICS INC 159,3412.4M $
30Glaukos Corp 20,8742.2M $
31Corbus Pharmaceuticals Holdings Inc 234,1362.2M $
32Penumbra Inc 6,3002.1M $
33Soleno Therapeutics Inc 61,6732.1M $
34Liquidia Corp 45,7961.7M $
35ZENAS BIOPHARMA INC 80,7301.6M $
36NovaBridge Biosciences 576,9601.4M $
374D Molecular Therapeutics Inc 130,5641.2M $
38NextCure Inc 115,5001.2M $
39Palisade Bio Inc 600,0001.1M $
40Lipocine Inc 60,861486.3K $